Issue details

Discretionary Rates Relief for Labcorp Drug Development (formerly known as Covance by Labcorp)

Decision type: Non-key

Decision status: Recommendations Approved

Wards affected: Beeston and Holbeck;

Notice of proposed decision first published: 01/10/2021

Department: Director of Resources

Contact: Tariq Sadiq, Inward Investment Manager 0113 378 6971 Email: tariq.sadiq@leeds.gov.uk.

Decisions